أعرض في EDS

S5. Validation of target genes within pathways shown to be up-regulated by AZD5363 treatment. from AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo

التفاصيل البيبلوغرافية
العنوان:	S5. Validation of target genes within pathways shown to be up-regulated by AZD5363 treatment. from AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo
المؤلفون:	Lesley-Ann Martin, Mitch Dowsett, Barry R. Davies, Stephen Johnston, Gianmaria Liccardi, Aradhana Rani, Hayley Campbell, Urszula M. Polanska, Nikiana Simigdala, Aurélie Thuleau, Qiong Gao, Elisabetta Marangoni, Stephanie K. Guest, Sunil Pancholi, Ricardo Ribas
بيانات النشر:	American Association for Cancer Research (AACR), 2023.
سنة النشر:	2023
الوصف:	MCF7 and MCF7-LTED cells lines were cultured in DCC {plus minus} AZD5363 and mRNA analysis performed by RT-qPCR. Error bars represent {plus minus} SEM. *p
الوصول الحر:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5b6b2ecbae87c4703d69fc67a915231Test https://doi.org/10.1158/1535-7163.22502725Test
حقوق:	OPEN
رقم الانضمام:	edsair.doi.dedup.....a5b6b2ecbae87c4703d69fc67a915231
قاعدة البيانات:	OpenAIRE

الوصف
الوصف غير متاح.